Iceland· IS-IS/1/12/140/02
Peratsin
A perphenazine product containing perphenazinum inn, registered in Iceland by Orion Corporation. The same ATC class is registered in 9 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Perphenazine is registered in 9 of 19 countries.
Countries holding a registration under ATC N05AB03 (perphenazine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 4 of them publish a price we can compare per daily dose
Perphenazine · ATC N05AB03
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Perphenazinum INN
- Manufacturer
- Orion Corporation
- Country
- Iceland (IS)
- ATC code
- N05AB03
- ATC class
- Perphenazine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean555235100 stk x1 glasISK 3665
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
371 interactions on record for perphenazine.
Graded by severity as the source publishes them — 49 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Perphenazine · interactions on record
371 records
- 49 severe
- 285 moderate
- 11 minor
- 24 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
2 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Perphenazine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesperphenazineZydus Lifesciences Limited
- United KingdomFentazin 4mg tabletsAdvanz Pharma
- NorwayPeratsinOrion
- CanadaPERPHENAZINEAA PHARMA INC
- FinlandPeratsinOrion Corporation Orion Pharma
- SpainDECENTAN 8 MG COMPRIMIDOSLaboratorios Ern S.A.
- GermanyPerphenazin NeuraxpharmNeuraxpharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Perphenazin Neuraxpharm
- Spain · Decentán
- Finland · Peratsin
- Italy · Trilafon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a251ffd-9a58-41d9-a0f1-bd74dfb00710 GET /v1/drugs/9a251ffd-9a58-41d9-a0f1-bd74dfb00710?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Húðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "N05AB03",
"marketed": true,
"strength": "4 mg",
"ma_number": "IS/1/12/140/02",
"substance": "Perphenazinum INN",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "41261"
}See everything about perphenazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.